diflorasone has been researched along with fluocinonide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francom, SF; Novak, E; Schlagel, CA | 1 |
| Amin, S; Kashani-Sabet, M; Zackheim, HS | 1 |
| Hecker, D; Lebwohl, M; Worsley, J; Yueh, G | 1 |
1 trial(s) available for diflorasone and fluocinonide
| Article | Year |
|---|---|
Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
Topics: Adult; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Random Allocation | 1983 |
2 other study(ies) available for diflorasone and fluocinonide
| Article | Year |
|---|---|
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Betamethasone; Betamethasone Valerate; Clobetasol; Drug Administration Schedule; Female; Fluocinonide; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Occlusive Dressings; Prospective Studies; Remission Induction; Skin Neoplasms; Treatment Outcome; Triamcinolone Acetonide | 1998 |
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis | 2000 |